{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:54:51Z","timestamp":1761562491900,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmig.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Minimally Invasive Gynecology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jmig.2019.03.019","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T22:17:42Z","timestamp":1553897862000},"page":"178-185.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Racial Disparities in Response to a US Food and Drug Administration Safety Communication Regarding the Use of Power Morcellation for the Treatment of Uterine Leiomyoma"],"prefix":"10.1016","volume":"27","author":[{"given":"Tomomi","family":"Matsushita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Sekizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa K.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmig.2019.03.019_bib0001","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2019.03.019_bib0002","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejogrb.2009.03.009","article-title":"Laparoscopic versus open myomectomy\u2014a meta-analysis of randomized controlled trials","volume":"145","author":"Jin","year":"2009","journal-title":"Eur J Obstet Gynaecol Reprod Biol"},{"key":"10.1016\/j.jmig.2019.03.019_bib0003","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/jama.2014.1093","article-title":"Evaluating the risks of electric uterine morcellation","volume":"311","author":"Kho","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jmig.2019.03.019_bib0004","unstructured":"US Food and Drug Administration. Laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA safety communication 2014. Available at: http:\/\/www.bogg.com\/custom\/images\/pdfs\/MorcellationNoticeFDA04\u201317\u20132014.pdf. Accessed February 22, 2018."},{"key":"10.1016\/j.jmig.2019.03.019_bib0005","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/AOG.0000000000002035","article-title":"Changes in myomectomy practice after the U.S. Food and Drug Administration safety communication on power morcellation","volume":"129","author":"Stentz","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2019.03.019_bib0006","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1097\/AOG.0000000000001111","article-title":"Association of the U.S. Food and Drug Administration morcellation warning with rates of minimally invasive hysterectomy and myomectomy","volume":"126","author":"Barron","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2019.03.019_bib0007","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.2016.9432","article-title":"Trends in use and outcomes of women undergoing hysterectomy with electric power morcellation","volume":"316","author":"Wright","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jmig.2019.03.019_bib0008","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/AOG.0000000000002309","article-title":"Change in surgical practice for women with leiomyomas after the U.S. Food and Drug Administration morcellator safety communication","volume":"130","author":"Clark","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2019.03.019_bib0009","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/AOG.0000000000002058","article-title":"Trends in mode of hysterectomy after the U.S. Food and Drug Administration power morcellation advisory","volume":"129","author":"Ottarsdottir","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2019.03.019_bib0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ajog.2015.08.047","article-title":"Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation","volume":"214","author":"Harris","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2019.03.019_bib0011","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ajog.2010.02.039","article-title":"Racial and ethnic disparities in benign gynecologic conditions and associated surgeries","volume":"202","author":"Jacoby","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2019.03.019_bib0012","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jmig.2013.08.709","article-title":"Disparities in use of laparoscopic hysterectomies: a nationwide analysis","volume":"21","author":"Patel","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jmig.2019.03.019_bib0013","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/AOG.0000000000002738","article-title":"Association of patient race with surgical practice and perioperative morbidity after myomectomy","volume":"132","author":"Stentz","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2019.03.019_bib0014","unstructured":"American College of Surgeons National Surgical Quality Improvement Program. User guide for the 2016 ACS NSQIP Participant use data file (PUF) 2016. Available at:https:\/\/www.facs.org\/\u223c\/media\/files\/quality%20programs\/nsqip\/nsqip_puf_userguide_2016.ashx. Accessed February 14, 2019."},{"key":"10.1016\/j.jmig.2019.03.019_bib0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0015-0282(97)81482-3","article-title":"Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors","volume":"68","author":"van Noord","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2019.03.019_bib0016","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1001\/jama.2015.15281","article-title":"Multiple imputation: a flexible tool for handling missing data","volume":"314","author":"Li","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jmig.2019.03.019_bib0017","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.brat.2016.11.008","article-title":"Multiple imputation as a flexible tool for missing data handling in clinical research","volume":"98","author":"Enders","year":"2017","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.jmig.2019.03.019_bib0018","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jmig.2015.08.010","article-title":"Trends over time and surgical outcomes of abdominal, mini-laparotomy, and traditional and robotic-assisted laparoscopy with and without tandem mini-laparotomy: a comparison of myomectomy techniques","volume":"22","author":"Stanhiser","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jmig.2019.03.019_bib0019","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2018.0141","article-title":"Practice patterns and complications of benign hysterectomy following the FDA statement warning against the use of power morcellation","volume":"153","author":"Multinu","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jmig.2019.03.019_bib0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jamaoncol.2014.206","article-title":"Use of electric power morcellation and prevalence of underlying cancer in women who undergo myomectomy","volume":"1","author":"Wright","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jmig.2019.03.019_bib0021","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jmig.2017.03.016","article-title":"Does universal insurance mitigate racial differences in minimally invasive hysterectomy?","volume":"24","author":"Ranjit","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jmig.2019.03.019_bib0022","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jmig.2018.05.017","article-title":"Relationship between race\/ethnicity and hysterectomy outcomes for benign gynecologic conditions","volume":"26","author":"Bougie","year":"2019","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jmig.2019.03.019_bib0023","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jamcollsurg.2016.04.047","article-title":"Surgical disparities: a comprehensive review and new conceptual framework","volume":"223","author":"Torain","year":"2016","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jmig.2019.03.019_bib0024","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.2196\/publichealth.9913","article-title":"Public awareness of uterine power morcellation through US Food and Drug Administration communications: analysis of google trends search term patterns","volume":"4","author":"Wood","year":"2018","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.jmig.2019.03.019_bib0025","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jmig.2016.01.019","article-title":"Impact of the 2014 Food and Drug Administration warnings against power morcellation","volume":"23","author":"Lum","year":"2016","journal-title":"J Minim Invasive Gynecol"}],"container-title":["Journal of Minimally Invasive Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155346501930144X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155346501930144X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:36:56Z","timestamp":1761557816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155346501930144X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S155346501930144X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmig.2019.03.019","relation":{},"ISSN":["1553-4650"],"issn-type":[{"type":"print","value":"1553-4650"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial Disparities in Response to a US Food and Drug Administration Safety Communication Regarding the Use of Power Morcellation for the Treatment of Uterine Leiomyoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Minimally Invasive Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmig.2019.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of AAGL.","name":"copyright","label":"Copyright"}]}}